Business
Eli Lilly Breaks Ground on $6.5B Houston Plant to Ramp Up Foundayo Production
CEO Dave Ricks says one-third of new GLP-1 pill patients are using Foundayo as Lilly invests heavily in US manufacturing capacity ahead…
CEO Dave Ricks says one-third of new GLP-1 pill patients are using Foundayo as Lilly invests heavily in US manufacturing capacity ahead…